12.07.2015 Views

Familial Nasopharyngeal Carcinoma 6

Familial Nasopharyngeal Carcinoma 6

Familial Nasopharyngeal Carcinoma 6

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

80 T. C. Putti and K-B. Tansections remains the cornerstone of NPC diagnosis,EBV encoded early RNA in situ hybridization (EBER-ISH) and cytokeratin immunohistochemistry are usefuladjuncts in diagnostically challenging cases.EBER-ISH is almost always positive in nonkeratinizingNPC, while it is negative in benign nasopharyngealepithelium and most other malignant differentialdiagnoses of NPC. Cytokeratin immunohistochemistryhelps highlight the irregular infiltrative nature ofNPC, contrasting with the regular surface and cryptalepithelium of normal biopsies. Malignant differentialdiagnoses that need to be distinguished from NPCinclude lymphoma, sinonasal carcinoma, and melanoma,while benign mimics include reactive lymphoidgerminal centers, crush artifacts, and postradiationchanges. For the assessment of suspected metastaticsites, FNAC has been shown to be a convenient andfairly accurate technique.ReferencesAl-Sarraf M, LeBlanc M, Giri PG, et al (1998) Chemotherapyversus radiotherapy in patients with advanced nasopharyngealcancer: phase III randomized intergroup study0099. J Clin Oncol 16:1310–1317Chan AB, Ma TK, Yu BK, et al (2004) <strong>Nasopharyngeal</strong> granulomatousinflammation and tuberculosis complicatingundifferentiated carcinoma. Otolaryngol Head Neck Surg130:125–130Chan CW, Nicholls JM, Sham JST, et al (1992) <strong>Nasopharyngeal</strong>carcinoma in situ in nasopharyngeal carcinoma. J ClinPathol 45:898–901Chan JKC, Pilch BZ, Kuo TT, et al (2005) <strong>Nasopharyngeal</strong> carcinoma.In: Barnes L, Eveson JW, Reichart P, Sidransky D(eds) World Health Organization classification of tumors.Pathology and genetics. Head and neck tumors. IARCPress, Lyon, pp 83–97Ertan Y, Hekimgil M, Karaarslan S, et al (2008) Expression ofEpstein–Barr-virus-encoded small nuclear RNA innasopharyngeal carcinomas of Aegean Turkish patients.Virchows Arch 452:411–414Glanzmann C, Aberle HG, Horst W (1976). Radiotherapyresults of nasopharyngeal carcinomas (41 patients)].Strahlentherapie 152:310–315Hwang TZ, Jin YT, Tsai ST (1998) EBER in situ hybridizationdifferentiates carcinomas originating from the sinonasalregion and the nasopharynx. Anticancer Res 18:4581–4584Ingeholm P, Theilgaard SA, Buchwald C, et al (2002)Esthesioneuroblastoma: a Danish clinicopathological studyof 40 consecutive cases. APMIS 110:639–645Inoue H, Sato Y, Tsuchiya B, et al (2002) Expression of Epstein–Barr virus-encoded small nuclear RNA 1 in Japanesenasopharyngeal carcinomas. Acta Otolaryngol Suppl 547:113–117Jeng YM, Sung MT, Fang CL, et al (2002) Sinonasal undifferentiatedcarcinoma and nasopharyngeal-type undifferentiatedcarcinoma: two clinically, biologically, and histopathologicallydistinct entities. Am J Surg Pathol 26: 371–376Lee JCK (1991) Precancerous changes. In: van Hasselt CA (ed)<strong>Nasopharyngeal</strong> carcinoma. Chinese University Press,Hong Kong, pp 37–45Müller E, Beleites E (2000) The basaloid squamous cell carcinomaof the nasopharynx. Rhinology 38:208–211Nascimento AF, Fletcher CD (2005) Spindle cell rhabdomyosarcomain adults. Am J Surg Pathol 29:1106–1113Pak MW, To KF, Lo YM, et al (2002) <strong>Nasopharyngeal</strong> carcinomain situ (NPCIS)-pathologic and clinical perspectives. HeadNeck 24:989–995Pathmanathan R, Prasad U, Sadler R, et al (1995) Clonal proliferationsof cells infected with Epstein–Barr virus in preinvasivelesions related to nasopharyngeal carcinoma. N EnglJ Med 333:693–698Shanmugaratnam K, Chan SH, de-Thé G, et al (1979)Histopathology of nasopharyngeal carcinoma: correlationswith epidemiology, survival rates and other biologicalcharacteristics. Cancer 44:1029–1044Shedd DP, von Essen CF, Eisenberg H (1967) Cancer of thenasopharynx in Connecticut, 1935 through 1959. Cancer20:508–511Sheu LF, Chen A, Meng CL, et al (1997) Analysis of bcl-2 expressionin normal, inflamed, dysplastic nasopharyngeal epithelia,and nasopharyngeal carcinoma: association withp53 expression. Hum Pathol 28:556–562Tan KB, Putti TC (2005) Cyclooxygenase 2 expression innasopharyngeal carcinoma: immunohistochemical findingsand potential implications. J Clin Pathol 58:535–538Teo WY, Tan HK, Goh BC, et al (2006) Postirradiation sarcomaof the sphenoid bone – a case report. Ann Acad MedSingapore 35:104–107Thompson LD, Wieneke JA, Miettinen M (2003) Sinonasaltract and nasopharyngeal melanomas: a clinicopathologicstudy of 115 cases with a proposed staging system. AmJ Surg Pathol 27:594–611Viguer JM, Jiménez-Heffernan JA, López-Ferrer P, et al (2005)Fine-needle aspiration cytology of metastatic nasopharyngealcarcinoma. Diagn Cytopathol 32:233–237Wan SK, Chan JK, Lau WH, et al (1995) Basaloid-squamous carcinomaof the nasopharynx. An Epstein–Barr virus-associatedneoplasm compared with morphologically identicaltumors occurring in other sites. Cancer 76:1689–1693Weiland LH (1985) <strong>Nasopharyngeal</strong> carcinoma. In: Barnes L(ed) Surgical pathology of the head and neck. MarcelDekker, New York, pp 453–466Wenig BM (2007) Tumors of the upper respiratory tract: partA: nasal cavity, paranasal sinuses and nasopharynx. In:Fletcher CDM (ed) Diagnostic Histopathology of Tumors,3rd edn. Elsevier, London, pp 83–149

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!